THERAPEUTICS FOR SILENT CANCERS

Therapeutics for Silent Cancers

The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.

This report provides:
-An overview of the global markets and technologies for the therapeutics for "silent" cancers.
-Analyses of global market trends, with data from 2013, 2014, and projections of CAGRs through 2019.
-Descriptions of cancers, with incidence and prevalence data for all major national markets.
-Assessments of currently available therapies.
-Evaluation of new agents now in clinical development, with likely launch timetables and estimates of potential clinical value.
-Profiles of major players in the "silent" cancer therapeutics industry.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for eight subtypes of cancer. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2019; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the cancer market. The wider economic environment is also taken into account.

The report examines strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market.

REASONS FOR DOING THE STUDY
The cancer market field is well provided with strategic and market reports but most concentrate on the most common cancers (breast, lung, colorectum, prostate). This report selects eight less-common cancers that are of market importance because they offer opportunities for successful drug therapy.

Read » Therapeutics for Silent Cancers

Published 1 week 1 day ago – Made popular 1 week 1 day ago
Category: Health | Tags:

Login or register to post comments

Stories similar to Therapeutics for Silent Cancers:

Additional information on Therapeutics for Silent Cancers :
- This BCC Research report discusses eight cancers described as “silent and deadly” worldwide. The market is quantified for each cancer, with estimates of recent ...
- Silence Therapeutics (LON:SLN) is a biotechnology company developing systematic RNA interference therapeutics for the treatment of cancer & other diseases.
- In particular, methods used to silence genes are being increasingly used to produce ... 4 Challenges to gene silencing therapeutics; 5 See also; 6 References .... utilized to study the potential use of siRNA molecules in cancer therapeutics.
- Curr Med Chem. 2015;22(5):552-68. Redox-active and Redox-silent Compounds : Synergistic Therapeutics in Cancer. Tomasetti M, Santarelli L, Alleva R, Dong ...
- Feb 2, 2010 ... For Silence Therapeutics' Atu-027 Cancer RNAi Therapeutic, the Proof is in the Pudding, not the Theory. This is the second part of the ...
- Jun 20, 2013 ... Among the first crop of systemic RNAi Therapeutics for cancer (see also CALAA01 by Arrowhead and ALN-VSP02 by Alnylam), Atu027 has ...
- Dec 5, 2014 ... NEW YORK (GenomeWeb) – Amid a growing interest into the therapeutic potential of messenger RNA, Silence Therapeutics has released ...
- Feb 21, 2012 ... 2012 German Science Day Dr. Klaus Giese, Chief Scientific Officer of Silence Therapeutics, presents at the German Science Day on 'The ...

Related links about Therapeutics for Silent Cancers :
1. Silence Therapeutics - Global RNAi Therapeutics Leader
2. Redox-active and redox-silent compounds: synergistic therapeutics ...
3. Silence Takes Aim at mRNA Therapeutics as RNAi Cancer Drug ...
4. Therapeutics for 'Silent' Cancers - PHM169A - BCC Research
5. Silence Therapeutics First to Advance Systemic Cancer RNAi ...

Global Markets for Generic Drugs 24 weeks 1 day ago

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

This report provides:

-An overview of the global market for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD.

Breast Cancer Diagnostic and Drug Technologies: Global Markets 12 weeks 6 days ago

The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019.

This report provides:
-An overview of the global market for breast cancer diagnostics and drug technologies.
-Analyses of market trends, with data from 2012, estimates for 2014, and projections of CAGRs through 2019.

RFID: Technology, Applications, and Global Markets 4 weeks 1 day ago

The global market for RFID (radio frequency identification) technologies was valued at roughly $9.7 billion in 2013 and increased to nearly $11.1 billion in 2014. By 2019, this market should approach $24 billion, with a compound annual growth rate (CAGR) of 16.7% for the five-year period, 2014 to 2019.

This report provides:
-An overview of the global markets for RFID technologies.
-Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
-Analysis of the importance of new technologies to the RFID industry as a whole.

Medical Aesthetic Devices: Technologies and Global Markets 19 weeks 2 days ago

REPORT HIGHLIGHTS

The global market for medical aesthetic devices reached $4.4 billion in 2013 and increasing to $4.6 billion in 2014. This market should reach nearly $6.2 billion in 2019, demonstrating a compound annual growth rate (CAGR) of 5.8% from 2014 to 2019.

This report provides:
-An overview of the global markets and technologies for medical aesthetic devices.
-Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
-Coverage of medical devices including:

Ultrafast Lasers: Technologies and Global Markets 2 weeks 21 hours ago

The global market for ultrafast lasers reached $1.2 billion and nearly $2 billion in 2013 and 2014, respectively. This market is expected to reach nearly $5.5 billion in 2019, registering a compound annual growth rate (CAGR) of 23.7% for the period 2014-2019.

This report provides:
-An overview of the global markets for ultra fast lasers and related technologies.
-Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.